Sangamo Therapeutics financials at a glance
| Year | Year | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.32M | $2.48M | $7.89M | $9.10M | $16.19M | $22.19M | $20.81M | $10.32M | $21.66M | $24.13M | $45.87M | $39.54M | $19.39M | $36.57M | $84.45M | $102.43M | $118.19M | $110.70M | $111.30M | $176.23M | $0.00M |
| GM % | Gross Margin % |
|
100.00% | 100.00% | 100.00% | 100.00% | 13.25% | 34.19% | -59.36% | -211.06% | -46.43% | -53.23% | -23.71% | -69.78% | -238.43% | -79.75% | -36.01% | -42.46% | -52.84% | -108.51% | -124.53% | -25.72% | 0.00% |
| OM | Operating Margin |
|
0.00% | 0.00% | -262.89% | -272.27% | -156.77% | -87.45% | -119.85% | 0.00% | -102.51% | -110.41% | -57.88% | -118.33% | 0.00% | -154.13% | -91.35% | -102.69% | -109.61% | -165.61% | -180.85% | -58.16% | 0.00% |
| EPS | Earnings Per Share |
|
$-0.51 | $-0.55 | $-0.58 | $-0.60 | $-0.44 | $-0.55 | $-0.71 | $-0.42 | $-0.47 | $-0.39 | $-0.58 | $-1.02 | $-0.70 | $-0.70 | $-0.85 | $-0.90 | $-1.23 | $-1.25 | $-0.61 | $0.00 | |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| PR % | Payout Ratio % |
|
0 | -0.00% | -0.00% | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -0.00% | -0.00% | 0 | -0.00% | -0.00% | -0.00% | 0 | 0 |
| Sha. | Shares |
|
25.19m | 25.42m | 33.94m | 40.14m | 40.98m | 44.91m | 45.22m | 52.47m | 52.99m | 61.8m | 68.4m | 70.05m | 70.62m | 84.52m | 102.09m | 115.94m | 141.44m | 143.88m | 145.97m | 177.35m | 177.35m |
| OCF | Operating Cash Flow |
|
$-10.16M | $-4.07M | $-14.48M | $-16.07M | $-17.35M | $-6.14M | $-23.93M | $-25.90M | $-8.08M | $-19.48M | $-5.68M | $-33.72M | $-65.88M | $11.18M | $36.55M | $-144.40M | $169.88M | $-233.25M | $-223.63M | $-224.84M | $0.00M |
| FCF | Free Cash Flow |
|
$-10.18M | $-4.50M | $-14.85M | $-17.44M | $-18.09M | $-6.41M | $-24.63M | $-26.48M | $-8.80M | $-19.91M | $-6.30M | $-36.13M | $-66.62M | $7.43M | $-5.91M | $-165.34M | $154.46M | $-256.53M | $-243.80M | $-240.80M | $0.00M |
| FCFS | Free Cash Flow Per Share |
|
$-0.41 | $-0.17 | $-0.46 | $-0.47 | $-0.44 | $-0.15 | $-0.55 | $-0.52 | $-0.17 | $-0.36 | $-0.08 | $-0.48 | $-0.94 | $0.10 | $-0.07 | $-1.47 | $1.15 | $-1.77 | $-1.58 | $-1.41 | $0.00 |